Drug class

Carbonic Anhydrase Inhibitors

Carbonic anhydrase inhibitors are a distinct pharmacologic class of medications that reversibly inhibit the zinc metalloenzyme carbonic anhydrase across multiple tissues. Read more about Carbonic Anhydrase Inhibitors

54 drugs in this class 44 manufacturers

Advertisement

Drugs in Carbonic Anhydrase Inhibitors

Showing 10–18 of 54 drugs

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS · OPEN ANGLE GLAUCOMA ·+4
ALEMBIC PHARMAC

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS · ABSENCE EPILEPSY ·+8
Major Pharamceuticals

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS · ABSENCE EPILEPSY ·+8
GSK Consumer Healthcare

DICHLORPHENAMIDE

CARBONIC ANHYDRASE INHIBITORS · FAMILIAL HYPERKALEMIC PERIODIC PARALYSIS ·+1
TORRENT PHARMAC

METHAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS · OPEN ANGLE GLAUCOMA ·+2
NORTHSTAR RX LL

METHAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS · OPEN ANGLE GLAUCOMA ·+2
BAUSCH & LOMB P
Filter & compare in the drug finder → Opens the drug finder with Carbonic Anhydrase Inhibitors preselected. Add indication or manufacturer filters there.

About Carbonic Anhydrase Inhibitors.

Carbonic anhydrase inhibitors are a distinct pharmacologic class of medications that reversibly inhibit the zinc metalloenzyme carbonic anhydrase across multiple tissues.

By blocking the interconversion of carbon dioxide and bicarbonate, these agents suppress bicarbonate reabsorption in the renal proximal tubules, reduce aqueous humor production in the ciliary body, and diminish cerebrospinal fluid secretion.

Clinically, they are primary therapies for lowering intraocular pressure in glaucoma and ocular hypertension, managing idiopathic intracranial hypertension, and preventing or treating acute altitude sickness.

They also serve as adjunctive therapies for selected seizure disorders and metabolic alkalosis, as well as mild diuretics in edematous states.